Introduction
============

Recent advances in genome editing using the type II bacterial clustered, regularly interspaced, palindromic repeats (CRISPR)-associated (Cas) system have enabled efficient genetic modification in the genomes of many organisms, including large animal models for biomedicine or agricultural purposes. Within the CRISPR/Cas9 system, the Cas9 from *Streptococcus pyogenes* recognizes a 5′-NGG-3′ PAM sequence on the non-target DNA strand, and allows complementation for 20-base-pair of target DNA sequence ([@B25]). However, unwanted off-target mutations and chromosomal translocations are potential drawbacks, raising concerns about the precision of the CRISPR/Cas system, which would prohibit its use in correcting human genetic diseases, and for optimal commercialization within livestock genetic improvement programs ([@B11]; [@B34]).

Off-target detection in advance is a challenge, as the existing proven analysis methods depend largely on amplification and sequencing of pre-selected off-target sites, identified by several bioinformatics tools \[e.g., CasOT ([@B44]), and CT-Finder ([@B47])\]. This approach can be more difficult to implement when the analysis aims to interrogate all possible non-unique matches and allowed mismatches distal from the PAM sequences. Compared with Sanger sequencing or short-reads deep sequencing of pre-selected off-target PCR amplicons, whole genome sequencing (WGS) is a less biased assessment of off-target mutations caused by Cas9. WGS is able to fully characterize the genome-wide mutation profiles, which not only include small insertion and deletions (indels) and SNPs but also structural variants such as inversions, rearrangements, duplications, and major deletions ([@B48]). This approach has been used to screen for off-target mutations induced by CRISPR/Cas9 in human cells ([@B35]; [@B19]), mice ([@B37]; [@B17]), and plants ([@B46]). Screening for off-target mutagenesis in gene-edited animals is rare and will be highly important in farm animal since gene editing brings the commercial benefits of improving the genetics of livestock, and also serves as a research model for biomedical studies. In addition, investigating the mutation profiles in the offspring of edited animals will provide fundamental evidence to support the reliability of the CRISPR/Cas9 system.

Genetically modified goats were successfully generated through multiplex injection of four sgRNAs targeting two functional genes (*MSTN* and *FGF5*) and Cas9 mRNA in one-cell-stage embryos ([@B42]). The desired phenotypes were independently observed in the edited animals. For example, disruption of *MSTN* caused increased muscle mass ([@B41]), while disruption of *FGF5* increased the number of secondary hair follicles and enhanced fiber length ([@B39]). Although healthy edited goats with ideal phenotypes were generated by this effort, the rate of genome-wide off-target mutations in the edited animals and their progenies have not been well documented. As such, 11 goats from four family trios were sequenced at a high coverage (\>36.8×), and the mutational profiles of these animals were systematically characterized to determine rates of off-target activity. The *de novo* mutation rate in the offspring were determined to be largely equivalent to the mutation rates of other populations such as human and cattle. Together with our previous results using trio-based WGS to show a low incidence of off-target mutations in gene-edited sheep ([@B40]), this work confirms the reliability of a multiplex-based CRISPR/Cas9 approach for the production of offspring from genetically modified large animal models that are intended for bio-medical studies and food production.

Materials and Methods {#s1}
=====================

Animals
-------

The genetically edited animals (Shaanbei Cashmere goat) used in the present study were generated previously ([@B42]). Two edited males (\#009 and \#040) were selected and mated with either edited (\#076, \#082, \#073) or wildtype (\#1392) female animals (same breed) after puberty (1.5 years old). All animals involved in this study were maintained at the Research Farm of Yulin University, Yulin, China. All protocols involving animals were approved by the College of Animal Science and Technology, Northwest A&F University (Approval ID: 2014ZX08008002). The pedigree information of these four family trios was validated by estimating the kinship coefficient according to a previous study ([@B26]), and were present in **Figure [1A](#F1){ref-type="fig"}**. Additional WGS data from two goat trios were selected as control trios for the present study (unpublished data).

![Animals used and the mutational spectra in the edited goat genome. **(A)** Animals used in this study. **(B)** Proportion of base changes in each animal in this study. Blue color represents male animals, while red color represents female animals. **(C)** Proportion of base changes in each family trio. **(D)** Nucleotide substitution ratios from paternal or maternal origins in the F1 progenies.](fgene-09-00449-g001){#F1}

Whole-Genome Sequencing and Data Analyses
-----------------------------------------

A total of 11 goats from four family trios were chosen for WGS (**Figure [1A](#F1){ref-type="fig"}**). For each animal, genomic DNA was extracted from peripheral venous blood samples with a Qiagen DNeasy Blood and Tissue Kit (Qiagen). To construct the WGS library, 1 μg of genomic DNA was fragmented to around 300 bp by ultrasonication using a Covaris S2 system. Then, the sheared DNA fragments were used for library construction using an Illumina TruSeq DNA library preparation kit at Novogene^[1](#fn01){ref-type="fn"}^. The final quality-ensured libraries were sequenced on an Illumina Hiseq 3000 for 125-bp paired-end reads. The raw sequencing reads were first filtered to remove low quality paired reads with the following criteria: (1) reads with \>10% N bases, (2) reads with \>50% bases with a sequencing quality of \<3, and (3) reads with residual length of \<40 bases after the adaptor sequences were trimmed. All reads that passed the quality control procedures were converted into FASTQ files.

To analyze the mutational classes in all the mutations, 12 different mutations were categorized into nine classes (T \> G, T \> C, T \> A, G \> T, G \> A, C \> T, A \> T, A \> G, and A \> C), and the base changes were measured in each animal and each family trio ([@B18]).

Identification of *de novo* Variants
------------------------------------

All reads after quality control were mapped to the goat reference sequence assembly ARS1 ([@B4]), using BWA (v0.7.13) tools ([@B23]) with default parameters. Local realignment and base quality re-calibration were conducted using the Genome Analysis Toolkit (GATK, v.2.7-2) ([@B28]). Both single nucleotide variants (SNVs) and indels (2--100 bp) were called using GATK and Samtools ([@B24]; [@B28]).

*De novo* SNVs and indels for each F1 animal were extracted according to the following criteria: (1) SNVs were independently identified by GATK and Samtools within a single trio, (2) choosing the overlapped SNVs that were identified by GATK and Samtools, and selecting the SNVs that were specific in each F1 animal; (3) filtering SNVs that exist in a goat SNP database (*n* = 234, 11 populations including 30 cashmere goats, \>79 million SNPs, unpublished data); (4) filtering SNVs with a read depth in parents \<12, and in F1 animals \<1/10 of the sum of the coverage in both parents ([@B1]; [@B18]); (5) the normalized phred-scaled likelihood (PL) scores for the genotypes (AA, AB, and BB) of F1 animals (A, reference allele; B, alternate allele), the PL scores for each genotype in founders should be \>20, 0, and \>0, the PL scores for each genotype in both parents should be 0, \>20, and \>20 ([@B1]); (6) filtering SNVs with \>10% average soft clipping per read; (7) manual examination to remove mis-aligned or miscalled SNVs/indels. Copy number variations (CNVs) were identified using a CNVcaller tool ([@B43]), we developed recently. The scanning window was defined as 400 bp, and the effective window value was set as 7, then the low-quality CNVs were removed manually. Structural variations (SVs) were independently detected using BreakDancer ([@B7]) and Lumpy ([@B22]) with suggested parameters. The detailed filtering pipelines for *de novo* SNVs are summarized in **Table [1](#T1){ref-type="table"}**.

###### 

Summary of filtering process for SNVs and indels in the F1 progenies.

  Variants                                                                   P59          P6           P97          P8           P9
  -------------------------------------------------------------------------- ------------ ------------ ------------ ------------ ------------
  ***SNVs***                                                                                                                     
     Called by GATK                                                          11,809,830   11,863,185   11,764,624   11,649,340   11,665,474
     Called by Samtools                                                      12,188,260   12,213,943   12,130,082   12,021,749   12,031,956
     GATK+Samtools                                                           1404         1461         9610         5839         7099
     Filtering using the goat SNP databases (*n* = 233, \>79 million SNPs)   1081         1174         3018         1526         1818
     Reads depth and allelic balance filtering                               136          166          166          139          127
     After PL scores, soft clipping, and ambiguous bases filtering           53           70           68           50           42
     After manual check                                                      18           18           24           11           14
     Validated by Sanger sequencing                                          11/15        7/9          --           --           5/7
     Mutation rate (×10^-8^)                                                 1.08         1.42         1.38         1.02         0.85
  ***Indels***                                                                                                                   
     Calledby GATK                                                           1,796,995    1,813,872    1,781,374    1,706,893    1,713,903
     Called by Samtools                                                      1,579,898    1,589,589    1,546,312    1,408,611    1,420,070
     GATK+Samtools                                                           815          898          3314         1198         1583
     Filtering using the goat SNP databases (*n* = 233, \>79 million SNPs)   187          233          562          181          222
     Reads depth and allelic balance filtering                               20           29           26           16           22
     After PL scores, soft clipping, and ambiguous bases filtering           7            14           7            2            7
     After manual check                                                      3            8            5            1            2
     Validated by Sanger sequencing                                          1/2          5/8          4/5          --           2/2

Prediction of Off-Target Sites
------------------------------

The putative off-target sites in the goat genome that might be recognized by the sgRNAs targeting the *MSTN* and *FGF5* genes were predicted by CasOT ([@B44]), and Cas-OFFinder ([@B3]). The potential off-target sites were defined as up to five mismatches according to a recent study ([@B6]). The detailed information of predicted off-target sites is summarized in **Supplementary Table [S1](#SM2){ref-type="supplementary-material"}**.

Estimation of Mutation Rate
---------------------------

The estimation of mutation rate per base pair per generation was calculated according to a recent study ([@B18]). Briefly, we retrieved short read sequences (.bam file) were retrieved by averaging the coverage in 10,000 base windows and the sequences from autosome genome within 13× to 130× coverage were selected. This resulted in 245,722 effective windows or 2,457,220,000 base pairs (R) within our coverage range. We then estimated the mutation rate per base pair per generation for each F1 animal by dividing the average number of *de novo* mutations (μ~α~) by twice the R account.
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Validation of Edited Sites, SNVs, and Indels
--------------------------------------------

PCR-based Sanger sequencing was conducted to validate the genetic regions with editing or the existence of *de novo* variants (SNVs or indels) identified by WGS. Primers for amplifying the edited sites or the regions encompassing *de novo* variants are listed in **Supplementary Tables [S2](#SM2){ref-type="supplementary-material"}, [S3](#SM2){ref-type="supplementary-material"}**. Procedures for the purification of PCR products, the T7E1 cleavage assay, and Sanger sequencing were conducted according to our previously report ([@B42]).

RNA Sequencing and Data Analysis
--------------------------------

Muscle from *MSTN*-edited and skin tissues from *FGF5*-edited F1 animals (*n* = 3) and wild-type animals (*n* = 3) at the same age (4-month) on the same farm, were collected for RNA-seq analysis. RNA extraction and sequencing were performed as described previously ([@B38]). Total RNA was isolated using Trizol Reagent (Invitrogen) and then treated with RNAse-free DNase I (Qiagen) according to the manufacturer's instructions. The quality and concentration of the total RNA were determined using an Agilent 2100 Bioanalyzer (Agilent). From each sample, 12 RNA libraries were constructed and oligo (dTs) were used to isolate poly (A) mRNA. The mRNA was fragmented and reverse transcribed using random primers. Second-strand cDNAs were synthesized using RNase H and DNA polymerase I. The double-strand cDNAs were then purified using the QiaQuick PCR extraction kit. The required fragments were purified via agarose gel electrophoresis and were enriched through PCR amplification. Finally, the amplified fragments were sequenced using Illumina HiSeq^TM^ 3000 system at Novogene (see text footnote 1), according to the manufacturer's instructions.

Among the raw data from RNA-seq, the sequencing adaptors, reads with unknown nucleotides larger than 5%, and the bases with low quality (more than half of the bases' qualities were less than 10) were removed. The remaining clean data was mapped to the currently available goat genome sequence assembly (ARS1) ([@B4]) using TopHat2 ([@B20]), to screen differentially expressed genes (DEGs). Counts for each gene were computed by means of the HTSeq Python package ([@B2]), and DEGs between the F1 progenies and control groups were determined with the EdgeR Bioconductor package using the classic method ([@B33]). Gene Ontology (GO) functional enrichment analysis was conducted using g: Profiler to identify the functional categories enriched in DEGs ([@B32]). The default settings were used, and GO terms with corrected *P*-value of less than 0.05 were considered significantly enriched.

The same RNA from muscle or skin tissues was used for qPCR analyses, to validate the RNA-seq results. First strand cDNA synthesized using the Thermo Scientific RevertAid First Strand cDNA Synthesis kit (\#K1622, Thermo Fisher Scientific, United States) under the manual instructions, and was then subjected to quantification using a standard SYBR Premix Ex Taq (Tli RNaseH Plus) kit (\#RR420A, Takara, China) on the Bio-Rad CFX96 Real-Time System. The primers for eight genes used for this study are listed in **Supplementary Table [S4](#SM2){ref-type="supplementary-material"}**. Biological and technical replicates were performed in triplicate for each sample. Gene relative expression was calculated using 2^-ΔΔCt^ method, quantified relative to the housekeeping gene *GAPDH*.

Immunofluorescent Staining and Western Blotting
-----------------------------------------------

The biopsied tissues were immediately fixed in 4% paraformaldehyde at 4°C overnight. The fixed tissues were then embedded in paraffin using standard immunohistochemical protocols. The immunofluorescence staining was conducted with anti-p53 (Cell Signaling Technology) primary antibody, the sections were then counterstained with Hoechst 33342 and analyzed by confocal laser microscopy. We extracted total protein from muscles, and then quantified the protein using the Bradford assay. Equal amounts of soluble protein were separated by SDS/PAGE and transferred onto a polyvinylidene difluoride membrane (PVDF, Roche). Immunoblotting was conducted using antibodies specific for phospho-p53 (Ser15) (Cell Signaling Technology, 1:1000), and β-actin (Proteintech, 1:1000). Primary antibodies were visualized using a fluorescence imager system (Sagecreation).

Results
=======

Generation of F1 Progenies
--------------------------

Cas9 mRNA and single guide RNAs targeting two functional genes, *MSTN* and *FGF5*, were multiplex-injected into one-cell-stage goat embryos, to generate animals with gene disruption ([@B42]). From this treatment, edited goats with improved phenotypes for muscling and fiber length were successfully obtained ([@B39], [@B41]). We then selected five founder animals (\#9, \#040, \#076, \#082, and \#073) and one wildtype individual (\#1392) for natural breeding, and obtained five F1 progenies (**Figure [1A](#F1){ref-type="fig"}**). We next genotyped the targeted sites in the progenies and their parents through Sanger sequencing. The genotypes of mutations at on-targeting site were validated by both WGS data (**Supplementary Figure [S1](#SM1){ref-type="supplementary-material"}**) and Sanger sequencing (**Supplementary Figure [S2](#SM1){ref-type="supplementary-material"}**). The sequencing data confirmed that the edited sites in the founder animals are successfully transmitted to their offspring, except the F1 animal \#P59 was wild-type at the *MSTN*\_sg1 locus, most likely because its dam is wildtype at this site (**Supplementary Figure [S2](#SM1){ref-type="supplementary-material"}**). In particular, mutations in \#009 were transmitted to the twin progeny \#P8 and \#P9, even though \#009 was mated with a wildtype female goat.

Deep Sequencing of Family-Trio Individuals
------------------------------------------

These 11 animals representing four family trios were subject to WGS variant analyses. The kinship coefficient values in each animal was used to ensure the correct pedigree information (**Supplementary Table [S5](#SM2){ref-type="supplementary-material"}**). WGS of 11 animal genomic DNAs yielded a total of 722 Gb of raw data, and produced between 516 and 944 million sequence reads mapped per animal (**Supplementary Table [S6](#SM2){ref-type="supplementary-material"}**). Over 99.02% of the generated sequence reads were mapped, indicating that high quality sequences were obtained. After alignment to the goat reference genome (ARS1) ([@B4]), an average of ∼36.8× (25.0--47.8×) sequencing depth were generated for further analysis (**Supplementary Table [S6](#SM2){ref-type="supplementary-material"}**).

Of all the SNVs identified by GATK, the mutation spectrums in each animal and each trio were analyzed. It was found that the C \> T, A \> G, G \> A, and T \> C substitutions are predominant in all the mutation types in each sequenced animal, and each base change type represents \>17% of base changes (**Figure [1B](#F1){ref-type="fig"}**). Additionally, the proportion of base changes in parents and offspring is non-significant in each trio (*p* = 0.326, Student's *t*-test) (**Supplementary Figure [S3](#SM1){ref-type="supplementary-material"}**). The base changes in each family trio were further examined, and no significant changes were found among the trios used for sequencing (**Figure [1C](#F1){ref-type="fig"}**). Moreover, we observed that the differences in nucleotide substitution patterns between paternal and maternal mutations in F1 animals were non-significant (**Figure [1D](#F1){ref-type="fig"}**).

Identification and Validation of *de novo* SNVs
-----------------------------------------------

To detect SNVs that may be derived from Cas9-mediated genetic modification, we employed a series of stringent variant filtering procedures (**Figure [2A](#F2){ref-type="fig"}** and **Table [1](#T1){ref-type="table"}**). We initially called \>11.6 million SNVs by GATK, and \>12.0 million SNVs by Samtools independently in each progeny. We then selected the specific SNVs in each F1 animal, and chose the SNVs that were both identities by GATK and Samtools. Next, any SNVs that already existed in the goat SNP database (294 individuals from 11 wild and domestic populations, \>79 million SNPs) were removed, and further filtering procedures included read depth, phred-scaled likelihood (PL) scores and manual examination according to a previous study ([@B1]). After manual check, 18, 24, 18, 11, and 14 SNVs remained in the F1 progenies P6, P97, P59, P8, and P9, respectively (**Table [1](#T1){ref-type="table"}** and **Supplementary Table [S4](#SM2){ref-type="supplementary-material"}**). These *de novo* SNVs were distributed in all chromosomes, and did not no cluster near the gene target sites (**Figure [2B](#F2){ref-type="fig"}**). We selected the SNVs from P6, P59, and P9 for PCR amplification followed by Sanger sequence validation, which confirmed that over 70% of SNVs truly exist (**Table [1](#T1){ref-type="table"}** and **Supplementary Table [S2](#SM2){ref-type="supplementary-material"}**). The germline *de novo* mutation rate (per base pair per generation) in these F1 progenies was estimated to range from 0.85 × 10^-8^--1.42 × 10^-8^ base substitutions per site per generation (**Table [1](#T1){ref-type="table"}**). We next predicted the genome-wide off-target sites using two programs, Cas-OT and Cas-OFFinder, we show that the vast majority of the off-targets identified by Cas-OFFinder were also included in the off-targets predicted by Cas-OT (**Figure [2C](#F2){ref-type="fig"}**). To ensure the reliability of predicted off-targets, we chose the overlapped off-targets for further analysis. The distance between 100,000 randomly selected SNV sites, and *de novo* SNVs to 534 predicted off-target sites were simulated (five mismatches) (**Supplementary Table [S1](#SM2){ref-type="supplementary-material"}** and **Supplementary Figure [S4](#SM1){ref-type="supplementary-material"}**), and no significant effects between the random selected SNVs and these *de novo* SNVs were observed from five F1 progenies, and two F1 animals from the control trios (*p* \> 0.05, Kolmogorov--Smirnov test) (**Figure [2D](#F2){ref-type="fig"}**). Together, these results indicated that *de novo* SNVs in the F1 progenies resulted from normal spontaneous mutagenesis rather than from CRISPR/Cas-mediated gene editing.

![Structural features of *de novo* mutations in the goat genome. **(A)** Workflow of filtering procedures of *de novo* variants in goat family trios. **(B)** Genomic distribution of *de novo* variants (SNVs, indels, and CNVs) in the goat genome. Red dots indicate the location of the two target sites in *MSTN* and *FGF5*. **(C)** Summary of off-target sites predicted by CasOT and Cas-OFFinder at each target site. **(D)** The distances between 100,000 randomly selected sites (upper), and *de novo* SNVs (below) to predicted off-target sites. The off-target sites were defined as one mismatch at seed regions, and up to four mismatches at non-seed regions. The least distance to predicted off-target sites was chosen. The area between two dashlines represents the 95% confidence interval. **(E)** Genomic distribution of SVs across the goat genome.](fgene-09-00449-g002){#F2}

Identification of Indels, CNVs, and SVs
---------------------------------------

Next, a comparative analysis within each trio was performed to identify for Cas9-induced small indels, given the possible likely outcomes of Cas9 induced double-strand breaks (DSB) repaired via non-homologous end-joining (NHEJ). Similar filtering procedures were used to screen candidate *de novo* indels as were conducted for *de novo* SNVs. After stringent indel filtering procedures including read depth, PL value and manual examination, a total of 19 indels were determined as *de novo* indels in all the five F1 animals (**Table [2](#T2){ref-type="table"}** and **Supplementary Table [S3](#SM2){ref-type="supplementary-material"}**). PCR-based Sanger sequencing confirmed the existence of 13 indels (**Table [1](#T1){ref-type="table"}** and **Supplementary Table [S3](#SM2){ref-type="supplementary-material"}**).

###### 

Identified candidate CNV and SVs in the F1 progenies.

  Variants                                                                                   P59    P6     P97    P8     P9
  ------------------------------------------------------------------------------------------ ------ ------ ------ ------ ------
  ***CNV***                                                                                                              
  Called by CNVcaller                                                                        1426   1016   2835   418    307
  Filtering by genotype and effective window                                                 6      8      15     5      2
  Candidate *de novo* CNVs                                                                   1      1      2      0      0
  ***SVs***                                                                                                              
  \(1\) Called by BreakDancer, and specific in F1 animals                                    1570   1411   1633   2058   2107
  After removal of common SVs in every two animals, and the read depth \<50%, manual check   3      9      13     12     13
  \(2\) Called by Lumpy                                                                      3609   3116   3406   2697   3082
  After removal of common SVs in every two animals, and the read depth \<50%, manual check   3      2      0      3      1

We next examined whether the large-scale genomic alterations (CNVs and SVs) could be attributed to Cas9 nucleases. CNVcaller ([@B43]) was used to search for CNVs, and after filtering CNVs by its genotypes and the effective window value, only four candidate CNVs were left in the F1 animals (**Figure [2B](#F2){ref-type="fig"}** and **Table [2](#T2){ref-type="table"}**). A number of SVs were identified using BreakDancer ([@B7]) and Lumpy ([@B22]), and only a few remained after filtering and were considered as candidate *de novo* SVs in each animal (**Figure [2E](#F2){ref-type="fig"}**, **Table [2](#T2){ref-type="table"}**, and **Supplementary Table [S7](#SM2){ref-type="supplementary-material"}**).

Analyzing of Off-Target Mutations
---------------------------------

To assess the off-target effects in F1 animals, we identified, using Cas-OFFinder, potential off-target sites with up to 3-nucleotide mismatches and NRG PAM sites in the goat genome. We then determined whether the *de novo* mutations, as well as the mutations that shared in parents and progenies were within the potential off-target sites, merely two indels were determined as off-target mutations (**Supplementary Table [S8](#SM2){ref-type="supplementary-material"}**). Sanger sequencing further validated these two variants (**Supplementary Figure [S5](#SM1){ref-type="supplementary-material"}**), indicating the off-target mutations are low in the offspring of edited animals and is guide RNA specific.

RNA-seq Analyses of Edited Animals
----------------------------------

We have recently analyzed the transcriptome profiles using muscle tissues from *MSTN* and/or *FGF5*-edited cashmere goats ([@B38]), and showed that the *MSTN*-disruption resulted in substantial changes in genes involved in lipid metabolism and biosynthesis. To better understand the transcriptional consequences of gene disruption in the genome of F1 progenies, we conducted transcriptome sequencing (RNA-seq) analysis in the edited progenies and WT animals using muscle or skin tissues. The volcano plot demonstrated that the expression of *MSTN* did not change significantly (**Figure [3A](#F3){ref-type="fig"}**). However, the disruption of *MSTN* resulted in 43 (23 up-regulated and 20 down-regulated) genes with significantly changed expression (**Figure [3C](#F3){ref-type="fig"}** and **Supplementary Table [S9](#SM2){ref-type="supplementary-material"}**). Some of these genes are known to be associated with muscle developmental including *FMOD*, *ARG2*, *TNMD*, *CSRP3*, *PCK2*, *EGR1*, and *TNC*. Meanwhile, disruption of *FGF5* led to the identification of 140 DEGs (74 up-regulated and 66 down-regulated) in the skins of F1 progenies and control animals (**Figures [3B,D](#F3){ref-type="fig"}** and **Supplementary Table [S10](#SM2){ref-type="supplementary-material"}**). Key regulators related to skin/hair follicle development such as *AQP3*, *AQP5*, *SPINK7*, and *WIF1* were involved, indicating that *FGF5* disruption may stimulate hair follicle functions resulting in increased fiber length ([@B39]). We performed qPCR on ten DEGs (including *MSTN* and *FGF5*) using RNA isolated from tissues of the same individuals. The validation results revealed a similar correlation between the RNA-seq and qPCR results (**Figures [3E,F](#F3){ref-type="fig"}** and **Supplementary Figure [S6](#SM1){ref-type="supplementary-material"}**), suggestion the reliability of RNA-seq analyses.

![Transcriptome analysis of gene targeting in the edited and WT animals. A volcano plot of gene expression patterns is shown in the edited and WT animals using muscle **(A)** or skin **(B)** tissues. **(C)** Heatmap of DEGs demonstrating unsupervised hierarchical clustering of *MSTN*-edited and WT animals in muscle tissues. **(D)** Heat maps of DEGs demonstrating unsupervised hierarchical clustering of *FGF5*-edited and WT animals in muscle tissues. Quantitative RT-PCR validation of the mRNA expression of *MSTN* in muscle **(E)**, and *FGF5* in skin tissues **(F)**. Enriched Gene Ontology terms using DEGs revealed in muscle **(G)** or skin **(H)** tissues.](fgene-09-00449-g003){#F3}

Subsequently, we performed GO enrichment analysis to predict the over-represented GO terms associated the DEGs identified in muscle and/or skin tissues. The DEGs identified in muscles exhibited significant over-representation of GO terms related to muscle fiber development (such as "sarcomere," "contractile fiber," and "myofibril") (**Figure [3G](#F3){ref-type="fig"}**). The DEGs identified in skins are significantly more enriched in GO terms related to skin and hair follicle development ("skin development," "keratinization," "keratinocyte differentiation," and "epidermis development") and immune responses ("granulocyte chemotaxis and migration," "leukocyte chemotaxis and migration," and "myeloid leukocyte migration") (**Figure [3H](#F3){ref-type="fig"}**).

Since two recent studies described that CRIPSR/Cas9-mediated genetic modification in normal cultured cells derived a p53-dependent toxic response ([@B12]; [@B16]), which may raise tumor risks. To validate this scenario in edited animals, we first investigated the expression of p53 and cell death-related genes retrieved from the RNA-seq data in skin and muscles, no significant gene expression changes were observed (**Figure [4A](#F4){ref-type="fig"}**). We further assessed the protein expression of p53 in the muscle of *MSTN*-disrupted animals. The immunofluorescence staining indicated no apparent changes of p53 expression in muscles between an edited animal (\#040) and controls (\#11) (**Figure [4B](#F4){ref-type="fig"}**). Western blotting further verified the p53 expression in muscles (**Figure [4C](#F4){ref-type="fig"}**). These results are consistent with the p53 expression in mice (personal communication), and suggested that Cas9-mediated modification did not induce apparent p53 expression changes in animal tissues. This result was probably due to p53-dependent molecular response in animal bodies may be differed with that in cultured cells ([@B12]), or the cellular response to DNA damage was repaired during the embryonic development process.

![p53 dependent expression in the muscles of edited animals and controls. **(A)** Heatmap of p53 and cell death related genes in F1 progenies and WT animals in muscle and skin tissues. **(B)** Immunofluorescence staining of muscles from a mutant (\#040) and a control animal (\#11) using anti-p53 antibodies (green) and counterstained with Hoechst 33342 (blue). Scale bar, 200 μm. **(C)** Western blot analysis using anti-p53 and anti-β-actin (control) antibodies in mutant (\#009, \#040, and \#082) and three controls (\#11, \#13, and \#15).](fgene-09-00449-g004){#F4}

Discussion
==========

Deep sequencing is able to fully characterize the mutational profiles in genomes, and is used to detect mutational changes in genetically edited organisms ([@B15]). In this study, through sequencing four family trios at a high coverage, the *de novo* variants in F1 animals that could be attributed to the engineered nucleases were determined to be neglectable, representing a low incidence of CRISPR/Cas9-mediated off-target mutations. On the other hand, our results further demonstrate the reliability of WGS in documenting mutations induced by genome editing.

Previous studies have shown that the *de novo* mutations exhibited variant type preferences and discriminative parental origins, and the mutational signatures were influenced by multiple factors including nucleotide type, sequence context, replication timing, and epigenetics. In this study, the mutational spectrum in genomes other than human and mice are reported. The C-T and A-G transitions were predominant in goat genomes, the enrichment of C \> T transitions at CpG dinucleotides could reflect spontaneous domination of methylated cytosine to thymine ([@B5]). We observed that the proportion of base changes was not significant in the parents or in the F1 progenies (**Figure [1C](#F1){ref-type="fig"}**), indicating the mutation profiles are largely stable in the edited animals and their offspring.

Mutation rate is a key parameter for calibrating the timescale of sequence divergence. The estimated average germline *de novo* SNV rate (per base pair per generation) in the present study is 1.15 × 10^-8^, which is equivalent to the average germline mutation rate in serval trio-based human populations including CEU (1.2 × 10^-8^) and YRI (1.0 × 10^-8^) ([@B9]), Icelanders (1.29 × 10^-8^) ([@B18]), Danish (1.28 × 10^-8^) ([@B27]), a large cattle population (1.2 × 10^-8^) ([@B13]), two goat trios (unpublished data), as well as three family trios of gene-edited sheep^16^ (**Figure [5](#F5){ref-type="fig"}**). These findings further supported the conclusion that the *de novo* SNVs in the F1 animals are generated naturally rather than induced by genetic modification.

![The mutation rates in edited goats and other populations.](fgene-09-00449-g005){#F5}

The CRISPR based approach relies on micro-injection of recombinant Cas9 mRNA/protein and guide RNAs and often results in off-target mutagenesis ([@B10]; [@B8]). Off-target sites predicted by different computational programs may have less overlaps ([@B36]). In the present study, Cas-OT recognized most of the off-targets that predicted by Cas-OFFinder, indicating the overlapped off-target sites are most likely represent the bona fide off-target sites for further analysis. Furthermore, our work presents trio-based WGS analysis to examine genome-wide *de novo* variants that may be induced by genetic modification in the F1 animals. Consistent with the off-target mutations observed in human cells ([@B37]; [@B45]), and mice ([@B17]), we observed low incident nuclease induced mutations in large animal models through deep sequencing. Therefore, supported the reliability of CRISPR approach for the production of viable animals.

We have previously demonstrated that disruption of *MSTN* in goats resulted in increased body weight and enlarged myofiber diameters in muscles ([@B41]), we also show disruption of the *FGF5* genes led to longer hair fibers in goats ([@B39]). To test the effect of Cas9-modification on global transcriptional status in the F1 progenies, we conducted RNA-seq on muscle and skin tissues to independently characterize the transcriptional consequences and genetic mechanism by knockout *MSTN* and *FGF5* in F1 progenies. Inconsistent with previous studies ([@B39], [@B41]), we did not observe significantly expression changes of both *MSTN* and *FGF5* with RNA-seq and validated by qPCR (**Figures [3E,F](#F3){ref-type="fig"}**). The plausible reason for this difference is animals from two generations were used for analyses. However, in the present study, we did identify a list of DEGs that are known to be associated with muscle development (e.g., *FMOD*, *ARG2*, *TNMD*, *CSRP3*, *PCK2*, *EGR1*, and *TNC*) in the muscle tissues of *MSTN*-disrupted animals, or skin and hair follicle development (*AQP3*, *AQP5*, *SPINK7*, and *WIF1*) in the skin tissues of *FGF5*-disrupted animals. Interestingly, functional enrichment analyses indicated that the DEGs are over-represented in GO terms associated with muscle fiber development in *MSTN*-disrupted goats, and GO terms related to skin development and immune responses in *FGF5*-edited animals. *MSTN* is primarily thought to inhibit muscle differentiation and growth ([@B31]; [@B29]), while *FGF5* represses hair growth by blocking dermal papilla cell activation ([@B14]; [@B30]). Therefore, it is plausible that disruption of these key regulators triggers multiple functional regulatory genes at post-transcriptional levels and eventually resulting in observed phenotypic changes.

Conclusion
==========

In summary, the present study provides a comprehensive analysis of genomes from edited animals and their progenies through deep sequencing. We provide sufficient evidence to show that the incidence of *de novo* mutations is low not only in edited founder animals ([@B40]), but also in the F1 progenies, and their mutation rate is not different from what normally occurs in wild type animals as spontaneous mutations. This study will serve as a valuable resource for evaluating the reliability of the CRISPR-based genome editing technologies in the engineering the genomes of large animals.
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